Lentivirus vectors expressing short hairpin RNAs against the U3-overlapping region of HIV nef inhibit HIV replication and infectivity in primary macrophages
- PMID: 16857988
- DOI: 10.1182/blood-2006-04-014829
Lentivirus vectors expressing short hairpin RNAs against the U3-overlapping region of HIV nef inhibit HIV replication and infectivity in primary macrophages
Abstract
Although successful attempts to inhibit HIV-1 replication in T cells using RNAi have been reported, the effect of HIV-specific RNAi on macrophages is not well known. Macrophages are key targets for anti-HIV-1 therapy because they are able to survive long after the initial infection with HIV and can spread the virus to T cells. In this study, we identified a putative RNAi target of HIV, consisting of the portion of the nef gene overlapping the U3 region (Nef366), and generated a lentivirus-based short hairpin RNA (shRNA) expression vector (Lenti shNef366). We show that Lenti shNef366 inhibits (1) HIV-1 replication in a monocytic cell line and in primary monocyte-derived macrophages (MDMs), (2) reactivation of latent HIV-1 infection, and (3) the production of secondary HIV-1 from MDMs harboring a genomic copy of Nef366. Moreover, we found that the up-regulated production of macrophage inflammatory protein 1beta (MIP-1beta), but not MIP-1alpha, in MDMs by Nef expression was considerably suppressed by Lenti shNef366, which suggests that HIV-1 dissemination to T cells through its interaction with HIV-1-infected MDMs can also be controlled by Lenti shNef366. Thus, lentivirus-mediated shRNA expression targeting the U3-overlapping region of HIV nef represents a feasible approach to genetic vaccine therapy for HIV-1.
Similar articles
-
HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages.Nat Med. 1999 Sep;5(9):997-103. doi: 10.1038/12433. Nat Med. 1999. PMID: 10470075 Free PMC article.
-
Nef: a pleiotropic modulator of primate lentivirus infectivity and pathogenesis.Acta Microbiol Immunol Hung. 2006 Mar;53(1):51-75. doi: 10.1556/AMicr.53.2006.1.4. Acta Microbiol Immunol Hung. 2006. PMID: 16696550 Review.
-
Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition.J Virol. 2004 Mar;78(5):2601-5. doi: 10.1128/jvi.78.5.2601-2605.2004. J Virol. 2004. PMID: 14963165 Free PMC article.
-
The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.J Exp Med. 1994 Jan 1;179(1):101-13. doi: 10.1084/jem.179.1.101. J Exp Med. 1994. PMID: 8270859 Free PMC article.
-
Nef performance in macrophages: the master orchestrator of viral persistence and spread.Curr HIV Res. 2011 Oct;9(7):505-13. doi: 10.2174/157016211798842080. Curr HIV Res. 2011. PMID: 22103834 Review.
Cited by
-
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma.Sci Transl Med. 2010 Jun 16;2(36):36ra43. doi: 10.1126/scitranslmed.3000931. Sci Transl Med. 2010. PMID: 20555022 Free PMC article. Clinical Trial.
-
Selective transmission of R5 HIV-1 over X4 HIV-1 at the dendritic cell-T cell infectious synapse is determined by the T cell activation state.PLoS Pathog. 2009 Jan;5(1):e1000279. doi: 10.1371/journal.ppat.1000279. Epub 2009 Jan 30. PLoS Pathog. 2009. PMID: 19180188 Free PMC article.
-
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques.Sci Rep. 2019 Apr 11;9(1):5917. doi: 10.1038/s41598-019-42253-3. Sci Rep. 2019. PMID: 30976083 Free PMC article.
-
RNAi screening: tips and techniques.Nat Immunol. 2009 Aug;10(8):799-804. doi: 10.1038/ni0809-799. Nat Immunol. 2009. PMID: 19621037 Free PMC article.
-
The therapeutic landscape of HIV-1 via genome editing.AIDS Res Ther. 2017 Jul 14;14(1):32. doi: 10.1186/s12981-017-0157-8. AIDS Res Ther. 2017. PMID: 28705213 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical